Skip to the main content
Cheque Size$1M to $50M
Stages2
Industries7
Markets20
Stated Portfolio3
Operating Since2016 (10y)

About Arieli Group

Arieli Group is a global investment firm committed to creating enduring prosperity. With a forward-thinking approach, the firm invests in early and growth-stage companies across industries including cybersecurity, defense, deep tech, healthcare, energy, fintech, and agritech. Rooted in a third-generation family office, Arieli Group is dedicated to building the next generation of technologies and driving them forward. The firm's investment strategy focuses on partnering with visionary entrepreneurs to transform bold ideas into groundbreaking technologies. Arieli Group provides capital and strategic support to help these companies scale and innovate, aiming to create a lasting impact across various sectors. The firm is actively involved in initiatives that bridge the gap between innovation and capital, fostering environments where cutting-edge research and pioneering projects can thrive. Arieli Group's track record includes partnerships with leading institutions such as Shaare Zedek Medical Center in Jerusalem, where they launched the SHAAR innovation hub to advance the city's healthtech ecosystem. Additionally, the firm has collaborated with Bar-Ilan University's technology transfer office, BIRAD, to accelerate the commercialization of pharmaceutical and life sciences innovations. These collaborations underscore Arieli Group's commitment to fostering innovation and driving progress in diverse industries.

Geographical Focus

African markets3

Other stated markets17

United StatesUnited KingdomCanadaGermanyJapanAustraliaChinaIndiaBrazilFranceUnited Arab EmiratesMexicoSouth KoreaSaudi ArabiaTurkeyRussiaIsrael

Requirements

Strong management team, Innovative technology, Scalable business model, Clear path to profitability, Alignment with Arieli Group's investment focus areas

Stated Portfolio3

SHAAR HealthTech Hub
BIRAD Pharmaceutical Innovations
Arieli Innovate Programs

As reported by the investor. We hold no profile for these companies, so they are printed as stated rather than linked.